Evidence map›Paper›PMID 32594560›Full record

ReviewCancer science2020

Nuclear microenvironment in cancer: Control through liquid-liquid phase separation.

Ryu-Suke Nozawa, Tatsuro Yamamoto, Motoko Takahashi, Hiroaki Tachiwana, Reo Maruyama, Toru Hirota, Noriko Saitoh

Abstract readReview
In one paragraph

Review in Cancer science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Targeting biomolecular condensates to inhibit breast cancer.Clinical and translational medicine · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ryu-Suke NozawaDivision of Experimental Pathology, The Cancer Institute of JFCR, Tokyo, Japan.
Tatsuro YamamotoDivision of Cancer Biology, The Cancer Institute of JFCR, Tokyo, Japan.
Motoko TakahashiDivision of Experimental Pathology, The Cancer Institute of JFCR, Tokyo, Japan.
Hiroaki TachiwanaDivision of Cancer Biology, The Cancer Institute of JFCR, Tokyo, Japan.
Reo MaruyamaProject for Cancer Epigenomics, The Cancer Institute of JFCR, Tokyo, Japan.
Toru HirotaDivision of Experimental Pathology, The Cancer Institute of JFCR, Tokyo, Japan.
Noriko SaitohDivision of Cancer Biology, The Cancer Institute of JFCR, Tokyo, Japan.ORCID https://orcid.org/0000-0002-2601-2806

Funding

DAIZ Inc.JSPS KAKENHI JP15H05977JSPS KAKENHI JP17H05013JSPS KAKENHI JP18H04034JSPS KAKENHI JP18H05531JSPS KAKENHI JP18K14629JSPS KAKENHI JP19K23736JSPS KAKENHI JP19K23736 JP17H05013 JP20K06496 JP20H05397 JP20H03190JSPS KAKENHI JP20H03190JSPS KAKENHI JP20H03520JSPS KAKENHI JP20H05397JSPS KAKENHI JP20K06496Naito FoundationPrincess Takamatsu Cancer Research FundTakeda Science FoundationUehara Memorial FoundationVehicle Racing Commemorative Foundation
6 · The paper itself

Abstract

The eukaryotic nucleus is not a homogenous single-spaced but a highly compartmentalized organelle, partitioned by various types of membraneless structures, including nucleoli, PML bodies, paraspeckles, DNA damage foci and RNA clouds. Over the past few decades, these nuclear structures have been implicated in biological reactions such as gene regulation and DNA damage response and repair, and are thought to provide "microenvironments," facilitating these reactions in the nucleus. Notably, an altered morphology of these nuclear structures is found in many cancers, which may relate to so-called "nuclear atypia" in histological examinations. While the diagnostic significance of nuclear atypia has been established, its nature has remained largely enigmatic and awaits characterization. Here, we review the emerging biophysical principles that govern biomolecular condensate assembly in the nucleus, namely, liquid-liquid phase separation (LLPS), to investigate the nature of the nuclear microenvironment. In the nucleus, LLPS is typically driven by multivalent interactions between proteins with intrinsically disordered regions, and is also facilitated by protein interaction with nucleic acids, including nuclear non-coding RNAs. Importantly, an altered LLPS leads to dysregulation of nuclear events and epigenetics, and often to tumorigenesis and tumor progression. We further note the possibility that LLPS could represent a new therapeutic target for cancer intervention.

Indexed as

Disease SusceptibilityBiomarkersCell NucleusChromatinGene Expression Regulation, NeoplasticHumansLiquid-Liquid ExtractionMitosisNeoplasmsProteomicsRNA, UntranslatedBiomarkersChromatinRNA, Untranslatedchromatin structureintrinsically disordered region/proteinliquid-liquid phase separationnon-coding RNAnuclear microenvironment

Identifiers

PMID32594560
PMCPMC7469853

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.